• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Biomatrica Announces Acquisition by Exact Sciences

Share:

October 22, 2018

Biomatrica, a leader in sample collection, is pleased to announce that it has been acquired by Exact Sciences Corp. Biomatrica will operate as a wholly owned subsidiary and will continue to supply sample preservation technologies to other companies.

Biomatrica’s biomarker collection portfolio includes LBgard® (blood collection tube for capturing circulating free DNA and cells for cancer screening and non-invasive pre-natal testing, RNAgard® (blood collection tube for capturing both RNA and DNA for gene expression analysis in a single tube, with true ambient transportation), and SalivaGard™ (a device for capturing DNA in saliva designed for high throughput processing with reduced contamination risk).

Biomatrica will continue to deploy its capabilities in Exact Sciences’ early cancer screening pipeline as well as with its expanding client base in diagnostics and consumer genomics.

Biomatrica will remain based in San Diego and terms of the deal are not being disclosed.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Date: October 22, 2018

Source: Biomatrica

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Afya Limited Announces Medicinae’s AcquisitionAfya Limited Announces Medicinae’s Acquisition
  • Fitbit, Bristol-Myers Squibb, Pfizer to Collaborate on Connection to Cardiac Care ResourcesFitbit, Bristol-Myers Squibb, Pfizer to Collaborate on Connection to Cardiac Care Resources
  • Mesa Biotech to Receive up to $15.4 Million Funding from the National Institutes of Health for Accelerated Scale-up and DeploymentMesa Biotech to Receive up to $15.4 Million Funding from the National Institutes of Health for Accelerated Scale-up and Deployment
  • Clinical AI’s Limitations: Some are Short-term, Others are UnavoidableClinical AI’s Limitations: Some are Short-term, Others are Unavoidable
  • Just One in Five Consumers Trust AI-Generated Healthcare AdviceJust One in Five Consumers Trust AI-Generated Healthcare Advice
  • Rafarma to be Acquired by R. & D. Biocogency Laboratories Inc.Rafarma to be Acquired by R. & D. Biocogency Laboratories Inc.
  • CTA Launches First-Ever Ansi-Accredited Standard for AI in HealthcareCTA Launches First-Ever Ansi-Accredited Standard for AI in Healthcare
  • Nursa Secures $80M to Expand Healthcare Staffing PlatformNursa Secures $80M to Expand Healthcare Staffing Platform

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications